Contemporary outcomes of iliofemoral bypass grafting for unilateral aortoiliac occlusive disease: A 10-year experience

被引:0
|
作者
Carsten, Christopher G., III [1 ]
Kalbaugh, Corey A. [1 ]
Langan, Eugene M., III [1 ]
Cass, Anna L. [1 ]
Cull, David L. [1 ]
Snyder, Bruce A. [1 ]
York, John W. [1 ]
Taylor, Spence M. [1 ]
机构
[1] Greenville Hosp Syst Univ Med Ctr, Acad Dept Surg, Vasc Surg Sect, Greenville, SC 29605 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Current treatment of complex aortoiliac occlusive disease (AIOD) includes the aortobifemoral bypass or the femoral-femoral bypass. However, because of bilateral groin exposure and associated risks, there is a significant morbidity associated with these procedures. In appropriate patients with unilateral AIOD, the iliofemoral bypass graft (IFBPG) via a lower abdominal retroperitoneal incision can be an acceptable alternative. The purpose of this study is to review the safety and efficacy as well as long-term outcomes of IFBPG in patients with unilateral AIOD. From July 1997 through June 2006, 40 patients (64.3 +/- 11.2-years-old, range 41-89-years-old, 57.5% critical limb ischemia, 70% male, 95% smokers) with unilateral AIOD were treated with IFBPG. Perioperative complications and symptom resolution were measured and Kaplan-Meier life table analysis was used to analyze outcomes of primary and secondary patency, survival, limb salvage, contralateral intervention, and maintenance of. ambulation and independent living status. The perioperative complication rate was 12.5 per cent (n = 5) including one patient who developed atrial-fibrillation and one who developed acute renal failure. Both patients experienced resolution of these symptoms before discharge. Other complications included one limb thrombosis and two wound infections. There were no perioperative deaths. Secondary patency was 97.5 per cent and 93.3 per cent at 1 and 5 years. Limb salvage in patients with critical limb ischemia (CLI) was 85.1 per cent and 79.1 per cent at 1 and 5 years. Limb amputation occurred due to infection (n = 2), or failed IFBPG (n = 2). Thirty-one patients (77.5%) experienced symptom resolution including 15 (88.2%) of the patients treated for claudication. Two patients (5%) required contralateral iliac intervention. Patient survival was 97.5 per cent and 64.5 per cent at 1 and 5 years. Greater than 90 per cent of patients maintained their functional independence at 5 years. IFBPG achieved excellent technical and functional outcomes, particularly in patients treated for vasculogenic claudication. This procedure is relatively safe and efficacious in a population of patients with complex unilateral AIOD and can be an acceptable alternative to the aortobifemoral bypass or fem-fem procedure.
引用
收藏
页码:555 / 559
页数:5
相关论文
共 50 条
  • [1] EXTRA-ANATOMIC BYPASS GRAFTING IN AORTOILIAC OCCLUSIVE DISEASE - 7-YEAR EXPERIENCE
    RICHARDSON, JV
    MCDOWELL, HA
    SOUTHERN MEDICAL JOURNAL, 1977, 70 (11) : 1287 - 1291
  • [2] Descending thoracic aorta to iliofemoral artery bypass grafting: A role for primary revascularization for aortoiliac occlusive disease?
    Passman, MA
    Farber, MA
    Criado, E
    Marston, WA
    Burnham, SJ
    Keagy, BA
    JOURNAL OF VASCULAR SURGERY, 1999, 29 (02) : 249 - 258
  • [3] Ten year outcomes after bypass surgery in aortoiliac occlusive disease
    Lee, Gwan-Chul
    Yang, Shin-Seok
    Park, Keun-Myoung
    Park, Yangjin
    Kim, Young-Wook
    Park, Kwang Bo
    Park, Hong Suk
    Do, Young-Soo
    Kim, Dong-Ik
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2012, 82 (06): : 365 - 369
  • [4] Descending thoracic aorta to iliofemoral artery bypass grafting: A role for primary revascularization for aortoiliac occlusive disease? Discussion
    McCarthy, WJ
    Passman, MA
    JOURNAL OF VASCULAR SURGERY, 1999, 29 (02) : 258 - 258
  • [5] Endovascular Approach Versus Aortobifemoral Bypass Grafting: Outcomes in Extensive Aortoiliac Occlusive Disease
    Rocha-Neves, Joao
    Ferreira, Andre
    Sousa, Joel
    Pereira-Neves, Antonio
    Vidoedo, Jose
    Alves, Helio
    Teixeira, Jose
    Azevedo, Ana
    VASCULAR AND ENDOVASCULAR SURGERY, 2020, 54 (02) : 102 - 110
  • [6] Trends in Aortofemoral Bypass for Aortoiliac Occlusive Disease: A Thirty-Year Experience
    Sharma, Gaurav
    Shah, Samir K.
    Scully, Rebecca E.
    Arnaoutakis, Dean J.
    Ozaki, C. Keith
    Belkin, Michael
    JOURNAL OF VASCULAR SURGERY, 2017, 65 (06) : 9S - 10S
  • [7] A Contemporary Comparison of Aortofemoral Bypass and Aortoiliac Stenting in the Treatment of Aortoiliac Occlusive Disease
    Burke, Christopher R.
    Henke, Peter K.
    Hernandez, Roland
    Rectenwald, John E.
    Krishnamurthy, Venkat
    Englesbe, Michael J.
    Kubus, James J.
    Escobar, Guillermo A.
    Upchurch, Gilbert R., Jr.
    Eliason, Jonathan L.
    ANNALS OF VASCULAR SURGERY, 2010, 24 (01) : 4 - 13
  • [8] Regarding "Descending thoracic aorta to iliofemoral artery bypass grafting: a role for primary revascularization for aortoiliac occlusive disease?" - Reply
    Passman, MA
    Keagy, BA
    JOURNAL OF VASCULAR SURGERY, 2000, 31 (02) : 410 - 411
  • [9] The crossover femoropopliteal bypass: A useful option for unilateral iliofemoral occlusive disease
    Chalmers, RTA
    Kerr, J
    Gillies, T
    Brittenden, J
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1996, 11 (03) : 330 - 334
  • [10] Outcomes after redo aortobifemoral bypass for aortoiliac occlusive disease
    Scali, Salvatore T.
    Schmit, Bradley M.
    Feezor, Robert J.
    Beck, Adam W.
    Chang, Catherine K.
    Waterman, Alyson L.
    Berceli, Scott A.
    Huber, Thomas S.
    JOURNAL OF VASCULAR SURGERY, 2014, 60 (02) : 346 - U102